These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 33061429)
1. MicroRNA-6071 Suppresses Glioblastoma Progression Through the Inhibition of PI3K/AKT/mTOR Pathway by Binding to ULBP2. Zhou Y; An H; Wu G Onco Targets Ther; 2020; 13():9429-9441. PubMed ID: 33061429 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene. Li KW; Wang SH; Wei X; Hou YZ; Li ZH Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway. Guan Y; He Y; Lv S; Hou X; Li L; Song J J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063 [TBL] [Abstract][Full Text] [Related]
5. Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway. Chen X; Zhang W; Xu X World J Surg Oncol; 2021 Aug; 19(1):232. PubMed ID: 34362378 [TBL] [Abstract][Full Text] [Related]
6. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation. Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973 [TBL] [Abstract][Full Text] [Related]
7. MiR-489-3p inhibits cell proliferation, migration, and invasion, and induces apoptosis, by targeting the BDNF-mediated PI3K/AKT pathway in glioblastoma. Zheng B; Chen T Open Life Sci; 2020; 15(1):274-283. PubMed ID: 33817216 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway. Lv X; Li CY; Han P; Xu XY Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway. Yang H; Song Z; Wu X; Wu Y; Liu C Onco Targets Ther; 2019; 12():5563-5575. PubMed ID: 31371994 [TBL] [Abstract][Full Text] [Related]
10. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells. Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169 [TBL] [Abstract][Full Text] [Related]
11. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway. Fan S; Yan S; Yang Y; Shang J; Hao M Onco Targets Ther; 2021; 14():2463-2473. PubMed ID: 33883901 [TBL] [Abstract][Full Text] [Related]
12. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines. Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804 [TBL] [Abstract][Full Text] [Related]
13. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2. Teng P; Jiao Y; Hao M; Tang X J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer. Ma T; Chen H; Wang P; Yang N; Bao J Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162 [No Abstract] [Full Text] [Related]
15. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway. Li YJ; Wang Y; Wang YY J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801 [TBL] [Abstract][Full Text] [Related]
16. MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway. Xiao J; Lin HY; Zhu YY; Zhu YP; Chen LW Onco Targets Ther; 2016; 9():5181-93. PubMed ID: 27578985 [TBL] [Abstract][Full Text] [Related]
17. miR-30b suppresses the progression of breast cancer through inhibition of the PI3K/Akt signaling pathway by targeting Derlin-1. Zhou J; Xiang AZ; Guo JF; Cui HD Transl Cancer Res; 2019 Feb; 8(1):180-190. PubMed ID: 35116747 [TBL] [Abstract][Full Text] [Related]
18. miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia. Wang D; Chen J; Ding Y; Kong H; You H; Zhao Y; Wei H; Liu Y Onco Targets Ther; 2020; 13():6681-6697. PubMed ID: 32764959 [TBL] [Abstract][Full Text] [Related]
19. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway. Cheng Y; Xie P J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386 [TBL] [Abstract][Full Text] [Related]
20. Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway. Zhu X; Zhu R Onco Targets Ther; 2018; 11():3521-3531. PubMed ID: 29950857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]